Medical Students Articles

Med Student

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chaudhary KR et al. - Treatment with the phosphoinositide 3-kinase (PI3K) inhibitor wortmannin abolished improved LVDP recovery in 11,12-EET-treated hearts but not did significantly inhibit recovery of rBNP-treated hearts.